Sort
16,300 grants matching “fatty liver disease”
Molecular mechanism of diet-induced carcinogenesis
$152,646Samson T Jacob · Ohio State University · R01 · FY2015 · CA
Fenofibrate for the treatment of patients with NASH
$152,581Hari S Conjeevaram · University Of Michigan At Ann Arbor · R03 · FY2006 · DK
In Vitro Liver Models to Investigate the Progression of Liver Fibrosis
$152,536Srivatsan Kidambi · University Of Nebraska Lincoln · P20 · FY2018 · GM
A Novel Role of IEX-1 in High Fat Diet-induced Obesity and Insulin Resistance
$152,460Mohd Shahid · Massachusetts General Hospital · K01 · FY2015 · DK
Nested Study: Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors
$152,422Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Microbial drivers of metabolically unhealthy obese phenotype
$152,388Devesha Kulkarni · University Of California Los Angeles · K01 · FY2025 · DK
Microbial drivers of metabolically unhealthy obese phenotype
$152,388Devesha Kulkarni · Washington University · K01 · FY2023 · DK
Microbial drivers of metabolically unhealthy obese phenotype
$152,388Devesha Kulkarni · Washington University · K01 · FY2024 · DK
Frailty and Functional Status in Older Liver Transplant Patients
$152,312Jennifer C. Lai · University Of California, San Francisco · K23 · FY2016 · AG
Avoiding toxicity associated with MTP ablation
$152,174M Mahmood Hussain · Suny Downstate Medical Center · R01 · FY2012 · HL
RECOMBINANT LEPTIN THERAPY FOR TREATMENT OF NASH
$152,167Elif Arioglu Oral · University Of Michigan At Ann Arbor · R03 · FY2006 · DK
Developmental effects of intestinal microbes on metabolic and behavioral circadian rhythms
$152,081Vanessa Anne Leone · University Of Wisconsin-Madison · R21 · FY2025 · DK
ETHANOL OXIDATION IN GENETICALLY MODIFIED CELLS
$152,055Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2001 · AA
Is Periodontal Disease Involved in the Etiology of Non-Alcoholic Fatty Liver Disease
$152,000Gary D Slade · Univ Of North Carolina Chapel Hill · R03 · FY2017 · DE
Is Periodontal Disease Involved in the Etiology of Non-Alcoholic Fatty Liver Disease
$152,000Gary D Slade · Univ Of North Carolina Chapel Hill · R03 · FY2016 · DE
Changes in T cell metabolism during graft-versus-host disease
$151,926Craig Alan Byersdorfer · University Of Pittsburgh At Pittsburgh · K08 · FY2016 · HL
Membrane-Based Mechanisms of Hepatic Insulin Resistance
$151,902Baran Ersoy · Weill Medical Coll Of Cornell Univ · K01 · FY2017 · DK
Membrane-Based Mechanisms of Hepatic Insulin Resistance
$151,902Baran Ersoy · Weill Medical Coll Of Cornell Univ · K01 · FY2016 · DK
Identification of autophagy mediators through screening transgenic animal library
$151,900Jun Hee Lee · University Of Michigan At Ann Arbor · R21 · FY2016 · OD
Adipogenesis and Insulin Resistance
$151,834Arthur Sherman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Integrin αvβ3 preclinical PET imaging to detect early stage NASH and treatment response
$151,800Tuo Shao · Massachusetts General Hospital · K01 · FY2022 · DK
Animal Phenotyping (Core B)
$151,772Gary J Schwartz · Columbia University Health Sciences · P30 · FY2024 · DK
Effects of Dietary Fat on the Hepatotoxicity of Environmental Arsenic
$151,769Walter H Watson · University Of Louisville · P20 · FY2018 · GM
Role of the bile acid activated receptors FXR and TGR5 in Total Parenteral Nutrition associated hepatic and gut disease
$151,632Ajay K. Jain · Saint Louis University · K08 · FY2019 · DK
Role of the bile acid activated receptors FXR and TGR5 in Total Parenteral Nutrition associated hepatic and gut disease
$151,632Ajay K. Jain · Saint Louis University · K08 · FY2020 · DK